Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Effect of Yoga Applied to Primiparous Pregnant Women on Postpartum Depression and Maternal Attachment

7 maggio 2026 aggiornato da: Handan ASATEKİN, Muş Alparslan University

The Effect of Yoga Applied to Primiparous Pregnant Women on Postpartum Depression and Maternal Attachment: A Randomised Controlled Trial.

This randomized controlled trial aims to evaluate the effects of an 8-week prenatal yoga intervention on postpartum depression and maternal attachment among primiparous pregnant women.

Panoramica dello studio

Stato

Attivo, non reclutante

Intervento / Trattamento

Descrizione dettagliata

Pregnancy is a physiological process for women; however, it is also a period that requires physical, mental, and social adaptation and is characterized by psychosocial changes, with a high risk of exposure to factors that may cause stress and anxiety. The extent to which pregnancy, considered a transition and adaptation period, is perceived as stressful varies greatly among individuals, and both the causes and perception of stress may differ between primiparous and multiparous women. Primiparous pregnant women experience many new and undefined emotions simultaneously and are unable to predict the events they may encounter during childbirth. Therefore, identifying and managing stress factors in the early stages is essential to support a positive pregnancy experience.Studies have shown that pregnant women generally perceive their prenatal stress levels as moderate to high, and that primiparous women experience higher levels of prenatal stress compared to multiparous women. Stress experienced during pregnancy may lead to numerous adverse effects on maternal, fetal, and neonatal health. It is suggested that stress during pregnancy is associated with postpartum depression. In addition, serious health problems such as depression and anxiety are commonly observed during pregnancy.Postpartum depression, also known as peripartum depression, is characterized by the onset of major depressive episode symptoms during the peripartum period. Its prevalence generally ranges between 10% and 20%, depending on the population and the timing and method of postpartum assessment. In our country, this rate varies between 12.5% and 28.1%. Postpartum depression affects mother-infant interactions such as breastfeeding, bonding, and maternal role functioning. By influencing the maternal role, postpartum depression negatively affects maternal attachment. Mothers with depressive symptoms tend to have lower levels of attachment and reduced sensitivity toward their infants.Maternal attachment refers to the emotional and behavioral bond established by the mother with her infant. This attachment process begins in the prenatal period and continues after birth as a reciprocal interaction between the mother and the baby. The mother-infant attachment process develops throughout pregnancy, childbirth, and the postpartum period and may be influenced by negative experiences related to these stages. As the level of postpartum depression increases, maternal attachment decreases. Mothers with postpartum depression have lower levels of maternal attachment compared to healthy mothers, and first-time motherhood has been associated with moderately impaired maternal bonding.Maternal attachment may begin during the prenatal period and is closely related to postpartum bonding. In the final trimester of pregnancy, women may experience ambivalent emotions toward their baby, feel discomfort related to pregnancy, desire the baby but fear childbirth, and experience higher levels of anxiety compared to earlier trimesters. Since maternal attachment is shaped through satisfactory and adequate interaction between the mother and the infant, it plays a significant role in reducing and minimizing symptoms of postpartum depression. Yoga, which has therapeutic effects on depression, stress, and anxiety, has been shown to positively influence the reduction of perceived maternal stress during pregnancy.Yoga is a mind-body practice that includes postures (asanas), deep breathing techniques (pranayama), and meditation. Asanas are specific physical positions that strengthen, purify, and balance the endocrine, nervous, and circulatory systems. When practiced regularly, asanas provide numerous physical and psychological benefits. Yoga is an adaptable form of exercise that can be easily modified and, when practiced regularly during pregnancy, can provide benefits for both the mother and the fetus.

Yoga during pregnancy has various psychological and physiological effects. It influences the release of beta-endorphins and neurotransmitters, leading to physiological and neurophysiological changes. By affecting the release of dopamine and serotonin, which are responsible for emotional regulation, it promotes relaxation. Regular yoga practice during the second and third trimesters has been found to be more effective than antenatal exercises in reducing anxiety and depression. Additionally, prenatal yoga has been reported to be effective in reducing depressive symptoms both during pregnancy and in the postpartum period.The prenatal and postnatal periods are distinct yet interconnected stages that play critical roles in the transition from pregnancy to early parenthood. These periods are important due to the associated risks of stress and postpartum depression. Therefore, women may consider yoga as an effective approach to facilitate adaptation to pregnancy and to cope with pregnancy-related challenges.

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Muş, Turchia (Türkiye)
        • Mus Alparslan University Campus, Diyarbakir Road 7th km, 49250 Mus Center/Mus

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Age ≥18
  • 26-28 weeks pregnant primipara
  • At least primary school education
  • Voluntary participation

Exclusion Criteria:

  • High-risk pregnancy
  • Chronic illness
  • Psychiatric diagnosis
  • Previous yoga/meditation experience

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Experimental: Prenatal Yoga
prenatal yoga-40-min/week for 8 week
In addition to routine prenatal care, participants in the intervention group will undergo an 8-week prenatal yoga program. The yoga protocol will be conducted once a week for 40 minutes per session. All sessions will be carried out face-to-face. Participants in the intervention group will complete the 8-week yoga program.
Nessun intervento: No İntervention: Control Group
Routine prenatal care only, walking 30-min 3 times week for 8 week

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postpartum Depression Score
Lasso di tempo: baseline and 1 months postpartum
The primary aim of this randomized controlled trial is to evaluate the effectiveness of an 8-week prenatal yoga invtervention on reducing postpartum depression in primiparous women compared to routine prenatal care. Measured by PDPI-R.The Postpartum Depression Predictors Inventory-Revised (PDPI-R) was developed to identify women at high risk for postpartum depression (PPD). It consists of two versions: the prenatal version and the postpartum/full version. The prenatal version is administered during pregnancy (third trimester) and consists of 32 items assessing 10 risk factors. The postpartum/full version, administered during the postpartum period, includes a total of 39 items by adding three risk factors specific to the postpartum period (7 items) to the factors included in the prenatal version (32 items).The total score of the prenatal version ranges from 0 to 32, while the total score of the postpartum/full version ranges from 0 to 39. Higher scores indicate a higher risk for PPD.
baseline and 1 months postpartum

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
maternal Attachment
Lasso di tempo: baseline and 1 month postpartum
the aim is to evaluate the effect of prenatal yoga on maternal-infant attachment at 1 month postpartum in primiparous women, measured by Maternal Attachment İnventory- MAI. It is administered to women who have babies between one and four months postpartum. The lowest score that can be obtained from the scale ranges from 26 to the highest score of 104, and a high score indicates a high level of maternal attachment.
baseline and 1 month postpartum

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

12 gennaio 2026

Completamento primario (Stimato)

20 giugno 2026

Completamento dello studio (Stimato)

10 luglio 2026

Date di iscrizione allo studio

Primo inviato

28 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

7 maggio 2026

Primo Inserito (Effettivo)

13 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

7 maggio 2026

Ultimo verificato

1 aprile 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Depressione, dopo il parto

Prove cliniche su prenatal yoga

Sottoscrivi